Charles River May 13, 2026 NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - TradingView
Charles River May 13, 2026 Charles River Laboratories stock (US1591881009): Shareholders approve 2026 incentive plan - AD HOC NEWS
Charles River May 13, 2026 Charles River, Medipost Sign MOU to Advance GMP Testing Solutions - Contract Pharma
Charles River May 12, 2026 Charles River Laboratories stock (US1591881009): Q1 earnings beat but FY2026 forecast cut - AD HOC NEWS
Charles River May 12, 2026 Charles River debuts AI diagnostic tool to cut down pathology timelines - Fierce Biotech
Charles River May 11, 2026 Charles River Laboratories Introduces AI-Powered, End-to-End Workflow - Contract Pharma
Charles River May 9, 2026 Charles River Laboratories stock (US1591881009): Shares dip after recent run-up as analysts eye upsi - AD HOC NEWS
Charles River May 7, 2026 Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations - StockStory
Charles River Apr 30, 2026 Charles River Laboratories Stock: Q1 2026 Earnings Release Scheduled for April 30 - AD HOC NEWS
Charles River Apr 23, 2026 Charles River Laboratories International Drops 7.2% Amid Sector-Wide Selling - AlphaStreet
Charles River Apr 21, 2026 Charles River Introduces First Rapid Animal-Free Bacterial Endotoxin Test - BioPharma APAC
Charles River Apr 10, 2026 Charles River flows into Boston to help AHA bridge cardiovascular health divide - Fierce Pharma
Charles River Mar 5, 2026 Charles River Laboratories International (CRL) Faces Biotech R&D Spending Headwinds - Yahoo Finance
Charles River Feb 27, 2026 Charles River Laboratories parts ways with its CDMO business | News - European Pharmaceutical Review
Charles River Feb 25, 2026 Charles River sells manufacturing and discovery businesses to fulfill promised pivot - Fierce Biotech
Charles River Feb 9, 2026 Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays - News-Medical